Official recall notice
FDA DrugClass INotable
FDA Recall: DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL single-dose vials, Sterile,
- Recall date
- 2026-06-17
- Category
- Drug
- FDA class
- Class I
Why it was recalled
Hazard
Presence of Particulate matter: Particulate matter identified as glass.
Recommended action
What to do
675 vials
Product description
Presence of Particulate matter: Particulate matter identified as glass.